Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BH | Biglari, Sardar | 10% Owner | 07/30/2026 | Verkauf | 16.70 | 273 | 4,559 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 07/29/2026 | Verkauf | 16.71 | 3,305 | 55,227 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 07/29/2026 | Verkauf | 16.71 | 3,306 | 55,243 | Form 4 |
| BHRB | Freeman Danyl R | Chief Human Resources Officer | 07/29/2026 | Steuer-Abgabe | 74.08 | 2,002 | 148,308 | Form 4 |
| BHRB | Freeman Danyl R | Chief Human Resources Officer | 07/29/2026 | Optionsausübung | 43.33 | 2,836 | 122,884 | Form 4 |
| BHRB | Boyle David P | Chair & CEO | 07/28/2026 | Schenkung | — | 1,752 | — | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 07/17/2026 | Verkauf | 16.71 | 11,000 | 183,810 | Form 4 |
| BHRB | Tissue Robert S | EVP, Financial Strategy | 07/17/2026 | Steuer-Abgabe | 72.85 | 9,777 | 712,254 | Form 4 |
| BHRB | Tissue Robert S | EVP, Financial Strategy | 07/17/2026 | Optionsausübung | 51.58 | 4,110 | 211,994 | Form 4 |
| BHRB | Tissue Robert S | EVP, Financial Strategy | 07/17/2026 | Optionsausübung | 47.47 | 8,599 | 408,195 | Form 4 |
| BHRB | Ritchie Bradford E | EVP, Chief Lending Officer | 07/16/2026 | Steuer-Abgabe | 70.76 | 2,222 | 157,229 | Form 4 |
| BHRB | Ritchie Bradford E | EVP, Chief Lending Officer | 07/16/2026 | Optionsausübung | 51.58 | 2,749 | 141,793 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 07/16/2026 | Verkauf | 16.70 | 2,749 | 45,908 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 07/15/2026 | Verkauf | 16.71 | 6,533 | 109,166 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 07/14/2026 | Verkauf | 16.73 | 1,211 | 20,260 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 07/13/2026 | Verkauf | 16.74 | 75,000 | 1,255,500 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).